Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Zhou

Showing results (221-230 of 340) with videos related to

Pageof 34
Sort By:
Tissue Engineering. Part A|January 6, 2024
Promoting a Cobalt Complex of Qingzhuan Dark Tea Polysaccharides on Fracture Healing in RatsMin Zheng, Yong Chen, Ziyao Wang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|December 19, 2023
[Blinatumomab as bridging therapy in two children with B-cell acute lymphoblastic leukemia complicated by invasive fungal disease]Xiao-Fei Liu, Xue Tang, Lu-Lu Wang, et al.
Genome Medicine|November 1, 2019
pTuneos: prioritizing tumor neoantigens from next-generation sequencing dataChi Zhou, Zhiting Wei, Zhanbing Zhang, et al.
Chemical Communications (Cambridge, England)|January 29, 2020
Flexible and printable dielectric polymer composite with tunable permittivity and thermal stabilityFeng Hu, Lu An, Aditya Tushar Chivate, et al.
Cell Systems|September 23, 2025
Weakly supervised peptide-TCR binding prediction facilitates neoantigen identificationYuli Gao, Yicheng Gao, Siqi Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 2, 2026
Menaquinone-7 preserves Prg4<sup>+</sup> chondrocytes from iron-driven damage in aging associated osteoarthritis by targeting GPR68/MAPK/GPX4 feed-forward loopQi He, Baihao Chen, Jiaxu Zeng, et al.
Frontiers in Immunology|February 16, 2024
Involvement and repair of epithelial barrier dysfunction in allergic diseasesHui-Fei Lu, Yi-Chi Zhou, Li-Tao Yang, et al.
Nature Communications|March 25, 2016
ELL targets c-Myc for proteasomal degradation and suppresses tumour growthYu Chen, Chi Zhou, Wei Ji, et al.
Hematology (Amsterdam, Netherlands)|November 25, 2024
Prevalence, trends, and outcomes of hematological malignancies in patients with hemophagocytic lymphohistiocytosisQi Zhang, Qiuyan Yu, Qian Chen, et al.
Nature Communications|May 23, 2023
Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growthYu Chen, Chi Zhou, Wei Ji, et al.
Pageof 34

Showing results (221-230 of 340) with videos related to

Sort By:
Pageof 34
Tissue Engineering. Part A|January 6, 2024
Promoting a Cobalt Complex of Qingzhuan Dark Tea Polysaccharides on Fracture Healing in RatsMin Zheng, Yong Chen, Ziyao Wang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|December 19, 2023
[Blinatumomab as bridging therapy in two children with B-cell acute lymphoblastic leukemia complicated by invasive fungal disease]Xiao-Fei Liu, Xue Tang, Lu-Lu Wang, et al.
Genome Medicine|November 1, 2019
pTuneos: prioritizing tumor neoantigens from next-generation sequencing dataChi Zhou, Zhiting Wei, Zhanbing Zhang, et al.
Chemical Communications (Cambridge, England)|January 29, 2020
Flexible and printable dielectric polymer composite with tunable permittivity and thermal stabilityFeng Hu, Lu An, Aditya Tushar Chivate, et al.
Cell Systems|September 23, 2025
Weakly supervised peptide-TCR binding prediction facilitates neoantigen identificationYuli Gao, Yicheng Gao, Siqi Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 2, 2026
Menaquinone-7 preserves Prg4<sup>+</sup> chondrocytes from iron-driven damage in aging associated osteoarthritis by targeting GPR68/MAPK/GPX4 feed-forward loopQi He, Baihao Chen, Jiaxu Zeng, et al.
Frontiers in Immunology|February 16, 2024
Involvement and repair of epithelial barrier dysfunction in allergic diseasesHui-Fei Lu, Yi-Chi Zhou, Li-Tao Yang, et al.
Nature Communications|March 25, 2016
ELL targets c-Myc for proteasomal degradation and suppresses tumour growthYu Chen, Chi Zhou, Wei Ji, et al.
Hematology (Amsterdam, Netherlands)|November 25, 2024
Prevalence, trends, and outcomes of hematological malignancies in patients with hemophagocytic lymphohistiocytosisQi Zhang, Qiuyan Yu, Qian Chen, et al.
Nature Communications|May 23, 2023
Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growthYu Chen, Chi Zhou, Wei Ji, et al.
Pageof 34